Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEVA PHARMACEUTICAL INDUSTRIES, LTD.”

302 pharma patents match "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 302
Index total 30,257
Page 4 / 13

Quick answer

This filtered view shows 302 pharmaceutical patents matching "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

302 results for “TEVA PHARMACEUTICAL INDUSTRIES, LTD.” · 30,257 patents in full index Clear search

  1. US 8389228

    Process for the measurement of the potency of glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  2. US 8383645

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  3. US 8367106

    Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  4. US 8367105

    Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  5. US 8334409

    Process for purifying rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted
  6. US 8329696

    Solid state forms of sitagliptin salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  7. US 8323634

    Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  8. US 8252933

    2-oxo-1,2-dihydro-quinoline modulators of immune function

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  9. US 8226977

    Pharmaceutical composition containing irbesartan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  10. US 8207361

    Tigecycline crystalline forms and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  11. US 8198470

    Crystalline form II of tigecycline and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  12. US 8198469

    Crystalline forms of tigecycline and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  13. US 8188149

    Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  14. US 8188067

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  15. US 8183373

    Solid state forms of sitagliptin salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  16. US 8178127

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  17. US 8178537

    Solid state forms of varenicline salts and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  18. US 8173615

    TRPM-2 antisense therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 8, 2012 · Expires May 3, 2032

    granted
  19. US 8163960

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  20. US 8158146

    Stable combinations of amlodipine besylate and benazepril hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  21. US 8148576

    Solid state forms of aliskiren compounds

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  22. US 8124644

    Carvedilol phosphate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  23. US 8114900

    Amorphous carvedilol dihydrogen phosphate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  24. US 8084630

    Process for the synthesis of ramelteon and its intermediates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted